A Study in Subjects With Retinitis Pigmentosa

Condition:   Retinitis Pigmentosa Intervention:   Drug: ADX-2191 Sponsor:   Aldeyra Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials